MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Paratek Pharmaceuticals Company Profile (NASDAQ:PRTK)

Consensus Ratings for Paratek Pharmaceuticals (NASDAQ:PRTK) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $31.83 (107.52% upside)

Analysts' Ratings History for Paratek Pharmaceuticals (NASDAQ:PRTK)
Show:
DateFirmActionRatingPrice TargetActions
5/16/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2016Leerink SwannReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2016Robert W. BairdInitiated CoverageOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015GuggenheimReiterated RatingBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015GabelliInitiated CoverageBuy$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015BTIG ResearchInitiated CoverageBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Ladenburg ThalmannInitiated CoverageBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha